Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTIVATE: Semaglutide and Exercise for Cognition in Older Adults with Type 2 Diabetes
NCT07485062Phase 4Not yet recruiting
- Sponsor
- Western University
- Start
- Sep 2026
- Primary completion
- May 2029
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in type 2 diabetes mellitus (T2DM), No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity., sponsored by Western University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.
Beyond the preview
Go deeper on NCT07485062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07485062.